Boylston, MA, United States of America

Ning Pan

This inventor holds 2 USPTO granted patents. Top assignees: Harvard College, University of Massachusetts. Active years: 2014-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ning Pan. Retrieved from https://idiyas.com/inventor/ning-pan-hkjus59g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ning Pan: Innovator in Type III Secretion Inhibitors

Introduction

Ning Pan is an accomplished inventor based in Boylston, MA (US). He holds 2 patents that focus on innovative solutions for inhibiting Type III secretion systems in pathogenic bacteria. His work is significant in the field of microbiology and disease prevention.

Latest Patents

Ning Pan's latest patents include compounds and compositions that are useful for inhibiting Type III secretion systems in pathogenic bacteria. The inventions relate to methods for discovering inhibitors of the Type III secretion system and their applications in the treatment and prevention of diseases. These advancements have the potential to impact public health positively.

Career Highlights

Throughout his career, Ning Pan has worked with prestigious institutions such as the University of Massachusetts and Harvard College. His contributions to research and innovation have been recognized in the scientific community.

Collaborations

Ning Pan has collaborated with notable colleagues, including Kyungae Lee and Jon Goguen. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions.

Conclusion

Ning Pan's work in developing Type III secretion inhibitors showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving health outcomes through innovative research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…